Analysis of the Efficacy and Stability of a Wearable ECG Monitor

Launched by MEZOO CO., LTD. · Aug 6, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness and safety of a new wearable heart monitor called HiCardi+, which is designed to keep track of heart activity in patients who have certain heart conditions like arrhythmias, bradycardia, and atrial fibrillation. The goal is to see how well this device works compared to a standard monitoring device used in hospitals. The trial will involve adults aged 19 and older who are admitted to Chonnam National University Hospital and need ECG monitoring. Participants will need to agree to be part of the study, either by providing consent themselves or through a family member.

If you join this study, you'll wear the HiCardi+ monitor along with another device that is commonly used in hospitals. The study is not yet recruiting participants, so it's not open for enrollment at this time. It's important to note that if someone cannot give consent or is not considered suitable by the researchers, they won't be able to participate. This trial aims to help improve heart monitoring methods, which could benefit future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adults aged 19 years or older
• • 2. Patients admitted to Chonnam National University Hospital who require ECG monitoring
• • 3. Individuals who have expressed their intention to participate in this study or have obtained written consent from a proxy
• Exclusion Criteria:
• • 1. Individuals who are unable to provide consent themselves or through a legally designated representative
• • 2. Individuals deemed unsuitable for participation in the clinical trial based on the researcher's judgment